Elicio Therapeutics (ELTX) Q2 2026 Earnings

11MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.87
-0.74
-0.6
-0.47

Details

Expected EPS
-0.465
Actual EPS
-0.65
Surprise EPS
-0.19
Surprise Percent
+39.78%

Description

Elicio Therapeutics (ELTX) has reported earnings of -0.65 per share for Q2 2026.

0 Comments

Share your thoughts